Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evidence for a role of macrophage migration inhibitory factor in vascular disease.

Arteriosclerosis, thrombosis, and vascular biology - 1 Apr 2004

Chen Zhiping, Sakuma Masashi, Zago Alexandre C, Zhang Xiaobin, Shi Can, Leng Lin, Mizue Yuka, Bucala Richard, Simon Daniel

Abstract excerpt

OBJECTIVE: Inflammation plays an essential role in atherosclerosis and restenosis. Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine that is widely expressed in vascular cells. However, there is no in vivo evidence that MIF participates directly in vascular injury and repair. Therefore, we investigated the effect of MIF blockade on the response to experimental angioplasty in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carotid Artery Injuries
Share to Chemotaxis, Leukocyte

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diet, Atherogenic

Share to Intramolecular Oxidoreductases

Share to Macrophage Migration-Inhibitory Factors

Share to Tunica Intima

Share to Tunica Media

Share to Vasculitis

Source

Identifiers

PMID: 14751814
DOI: 10.1161/01.ATV.0000119356.35748.9e

Genes

MIF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evidence for a role of macrophage migration inhibitory factor in vascular disease.PMID 14751814Read ↗

Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice.Semantic proximity Read ↗

Macrophage migration inhibitory factor triggers vascular smooth muscle cell dedifferentiation by a p68-serum response factor axis.Semantic proximity Read ↗

Stress and vascular responses: anti-inflammatory therapeutic strategy against atherosclerosis and restenosis after coronary intervention.Semantic proximity Read ↗

Link between aging and atheroprotection in <i>Mif</i> -deficient atherosclerotic miceSemantic proximity Read ↗

Molecular mechanisms mediating inflammation in vascular disease: special reference to monocyte chemoattractant protein-1.Semantic proximity Read ↗

Inflammatory cell recruitment in cardiovascular disease: murine models and potential clinical applicationsSemantic proximity Read ↗

Anti-monocyte chemoattractant protein-1 gene therapy inhibits restenotic changes (neointimal hyperplasia) after balloon injury in rats and monkeys.Semantic proximity Read ↗

Role of macrophage-derived hypoxia-inducible factor (HIF)-1α as a mediator of vascular remodelling.Semantic proximity Read ↗

BMP-2 and -4 produced by vascular smooth muscle cells from atherosclerotic lesions induce monocyte chemotaxis through direct BMPRII activation.Semantic proximity Read ↗

Latexin facilitates neointimal formation via promoting smooth muscle cell proliferation and macrophage migrationSemantic proximity Read ↗

Mechanisms of post-intervention arterial remodelling.Semantic proximity Read ↗

Mif-deficiency favors an atheroprotective autoantibody phenotype in atherosclerosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.